Today a new European initiative was announced that will work to build a collaborative platform for data and sample sharing, to accelerate the discovery and validation of biomarkers for neurodegenerative diseases.
The European Platform for Neurodegenerative Diseases (EPND) is a public-private partnership funded by the Innovative Medicines Initiative (IMI), a Joint Undertaking between the EU and European pharmaceutical industries that supports projects at the vanguard of health research.